Thomson Reuters/Uni...
Health Care: Drugs
Novavax Inc. (NVAX: NASDAQ)
$2.01 -0.05 | -2.43%
05/17/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with NVAX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorBreakout Stocks Of The Week...
- UserCy Winther
- UserNale's Holdings
- Contributor10 Pharma Stocks Under $3
- Contributor10 Stocks Under $3 With Upside
- Contributor10 Stocks Under $4 With Upside
- Usergdean1
- Userhisatomi
- UserBruce7677
Latest NVAX Headlines from TheStreet
- Novavax H7N9 VLP Influenza Vaccine Enters Animal Testing 05.10.13 | 08:05 am
- Novavax Reports First-Quarter 2013 Financial Results 05.07.13 | 08:05 am
- Novavax To Report First-Quarter 2013 Financial Results On May 7, 2013 04.26.13 | 08:04 am
- Novavax To Present At 12th Annual Needham Healthcare Conference 04.25.13 | 08:04 am
- Novavax To Review Recent Findings From Vaccine Programs At World Vaccine Congress And Expo In Washington, DC 04.15.13 | 05:04 pm
- Novavax Appoints Amy B. Fix Vice President Of Regulatory Affairs 04.10.13 | 08:04 am
- Novavax Reports Positive Top-Line Results From Phase II Clinical Trial Of RSV Vaccine Candidate In Women Of Childbearing Age 04.02.13 | 04:04 pm
- Novavax Reports Progress On RSV Vaccine At The XV International Symposium On Respiratory Viral Infections 03.18.13 | 08:03 am
- 5 Stocks With Big Insider Buying 03.13.13 | 12:03 pm
- Novavax To Present At The 25th Annual ROTH Conference 03.13.13 | 12:03 pm
Press Releases for NVAX
- U.S. Life Science Companies Raise $53 Million Through Activity Of 19 At-the-Market (ATM) Offerings In First Quarter Of 2011, Data From Brinson Patrick Securities Show - PR Newswire 06.23.11 | 07:06 am
- MLV Announces Formation Of Advisory Board And Appointment Of Dr. Rahul Singhvi As Its Founding Director - PR Newswire 06.03.11 | 10:06 am
- NOVAVAX To Present At The NOBLE FINANCIAL 7th Annual Equity Conference - PR Newswire 05.13.11 | 11:05 am
- Novavax Named Biotechnology Firm Of The Year By Tech Council Of Maryland - PR Newswire 05.11.11 | 09:05 am
- Novavax To Report First Quarter 2011 Financial Results On May 9, 2011 - PR Newswire 05.03.11 | 10:05 am
- Novavax Announces Senior Management Appointments - PR Newswire 04.26.11 | 08:04 am
- Novavax Announces Change In Leadership - PR Newswire 04.19.11 | 04:04 pm
- Novavax's VLP Influenza Vaccine Named One Of Top 100 Drugs In Development Today - PR Newswire 04.05.11 | 08:04 am
- NOVAVAX Announces Release Date Of 2010 Year-End Financial Results And Investor Conference Call - PR Newswire 03.23.11 | 02:03 pm
- NOVAVAX To Present At BIT Life Science's 3rd World Congress Of Vaccine - PR Newswire 03.22.11 | 08:03 am
Partner Headlines for NVAX
- Novavax Initiates Phase 2 Trial of RSV Vaccine; Sees Reporting Top-Line Results in Q1 2013 - Benzinga 10.08.12 | 01:10 pm
- Johnson & Johnson Gets CERTIFIED and 4 Stocks Enjoying 52-Week Highs - Wall St. Cheat Sheet 07.19.12 | 10:07 am
- NOVAVAX Launches Phase II Clinical Trial of Seasonal Influenza Vaccine - Benzinga 03.01.12 | 04:03 pm
- Oink Oink: Profit From The Return Of Swine Flu - Benzinga 01.12.12 | 01:01 pm
- Gambling With Speculative Healthcare Stocks - Seeking Alpha 09.06.11 | 09:09 am
- Novavax Gets a Federal Grant for Developing Its Novel Flu Vaccine - AOL 03.01.11 | 08:03 pm
- UPDATE 1-FDA clears Novavax trial for anti-viral vaccine - Reuters 12.16.10 | 08:12 am
- Novavax 2Q Earnings Down on High R&D Costs - Fox Business 08.06.10 | 01:08 pm
- UPDATE 1-Novavax flu vaccine trial shows mildly positive results - Reuters 04.29.10 | 09:04 am
- UPDATE 1-Novavax reports positive data from flu vaccine study - Reuters 03.24.10 | 08:03 am
